As per FMI – an ESOMAR-certified market research firm, the global pharmaceutical lipids market is expected to witness a CAGR of over 5.2% and surpass USD 7 Bn by 2031.The pharmaceutical lipids market players are focusing on Lipid nanocarriers are being increasingly used in the form of drug delivery systems as they a.
Search jobs USD 7 Billion Worth of Pharmaceutical Lipids will be Sold by 2030
As per FMI – an ESOMAR-certified market research firm, the global pharmaceutical lipids market is expected to witness
a CAGR of over 5% and surpass USD 7 Bn by 2030.
The pharmaceutical lipids market players are focusing on Lipid nanocarriers are being increasingly used in the form of drug delivery systems as they are reported to be less toxic and render better biocompatibility in comparison with polymeric nanoparticles. This factor is prompting market players to switch over to lipid-based formulations and the trend is expected to continue in the forecast period as well.